Des-γ-carboxy prothrombin stimulates human vascular endothelial cell growth and migration

Clinical and Experimental Metastasis

Volumn 26, Issue 5, 2009, Pages 469-477

  Wang, Su Bo ^a   Cheng, Yan Na ^b   Cui, Shu Xiang ^c   Zhong, Julia Li ^d   Ward, S G ^d   Sun, Li Rui ^b   Chen, Ming Hui ^b   Kokudo, Norihiro ^e   Tang, Wei ^e   Qu, Xian Jun ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^d University of Bath   (United Kingdom)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenesis; DCP; EGFR; HCC; Human vascular endothelial cell; MMP 2; VEGF

Indexed keywords

BIOLOGICAL MARKER; DECARBOXYPROTHROMBIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; MATRIGEL; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SECRETION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; VASCULAR ENDOTHELIUM;

BIOLOGICAL MARKERS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 2; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN PRECURSORS; PROTEOGLYCANS; PROTHROMBIN; RECEPTOR, EPIDERMAL GROWTH FACTOR; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67349183382     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-009-9246-y     Document Type: Article

References (35)

1. HA Liebman 1989 Isolation and characterization of a hepatoma-associated abnormal (des-gamma-carboxy) prothrombin Cancer Res 49 23 6493 6497 (Pubitemid 20008776)
2. Y Kim do YH Paik SH Ahn 2007 PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection Oncology 72 Suppl 1 52 57 10.1159/000111707
3. MF Yuen CL Lai 2005 Serological markers of liver cancer Best Pract Res Clin Gastroenterol 19 1 91 99 10.1016/j.bpg.2004.10.003
4. T Naraki N Kohno H Saito 2002 γ-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin Biochim Biophys Acta 1586 3 287 298 10.1016/S0925-4439(01)00107-7
5. M Suzuki H Shiraha T Fujikawa 2005 Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma J Biol Chem 280 8 6409 6415 10.1074/jbc.M406714200
6. FJ Gao SX Cui MH Chen 2008 Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells Life Sci 83 23-24 815 820 10.1016/j.lfs.2008.10.003
7. RW Pang JW Joh PJ Johnson 2008 Biology of hepatocellular carcinoma Ann Surg Oncol 15 4 962 971 10.1245/s10434-007-9730-z
8. K Shirabe S Itoh T Yoshizumi 2007 The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin J Surg Oncol 95 3 235 240 10.1002/jso.20655
9. S Kitai M Kudo Y Minami 2008 A new prognostic staging system for hepatocellular carcinoma: value of the biomarker combined Japan integrated staging score Intervirology 51 Suppl 1 86 94 10.1159/000122599
10. T Fujikawa H Shiraha N Ueda 2007 Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration J Biol Chem 282 12 8741 8748 10.1074/jbc.M609358200
11. J Liu X Li YN Cheng 2007 Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil Eur J Pharmacol 574 1 1 7 10.1016/j.ejphar.2007.06.064
12. P Dua RP Gude 2008 Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation Eur J Cancer 44 11 1587 1595 10.1016/j.ejca.2008.04.009
13. P Subarsky RP Hill 2008 Graded hypoxia modulates the invasive potential of HT1080 fibrosarcoma and MDA MB231 carcinoma cells Clin Exp Metastasis 25 3 253 264 10.1007/s10585-007-9139-x
14. PY Yue DY Wong PK Wu 2006 The angiosuppressive effects of 20(R)-ginsenoside Rg3 Biochem Pharmacol 72 4 437 445 10.1016/j.bcp.2006.04.034
15. K Park YS Kim GY Lee 2007 Antiangiogenic effect of bile acid acylated heparin derivative Pharm Res 24 1 176 185 10.1007/s11095-006-9139-6
16. B Okutucu A Dincer O Habib 2007 Comparison of five methods for determination of total plasma protein concentration J Biochem Biophys Methods 70 5 709 711 10.1016/j.jbbm.2007.05.009
17. Z Li Z Zhou HJ Donahue 2008 Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential Clin Exp Metastasis 25 3 265 272 10.1007/s10585-007-9140-4
18. S Uehara K Gotoh H Handa 2005 Distribution of the heterogeneity of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma J Gastroenterol Hepatol 20 10 1545 1552 10.1111/j.1440-1746.2005.03899.x
19. T Sugino T Yamaguchi N Hoshi 2008 Sinusoidal tumor angiogenesis is a key component in hepatocellular carcinoma metastasis Clin Exp Metastasis 25 7 835 841 10.1007/s10585-008-9199-6
20. J Mojzis L Varinska G Mojzisova 2008 Antiangiogenic effects of flavonoids and chalcones Pharmacol Res 57 4 259 265 10.1016/j.phrs.2008.02.005
21. M Klagsbrun MA Moses 1999 Molecular angiogenesis Chem Biol 6 8 R217 R224 10.1016/S1074-5521(99)80081-7
22. LE Kemp B Mulloy E Cherardi 2006 Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors Biochem Soc Trans 34 Pt 3 414 417 10.1042/BST0340414
23. WS Moon HS Park KH Yu 2006 Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis Hum Pathol 37 10 1324 1332 10.1016/j.humpath.2006.04.022
24. PC Black CP Dinney 2007 Bladder cancer angiogenesis and metastasis-translation from murine model to clinical trial Cancer Metastasis Rev 26 3-4 623 634 10.1007/s10555-007-9084-9
25. AX Zhu E Raymond 2009 Early development of sunitinib in hepatocellular carcinoma Expert Rev Anticancer Thera 9 1 143 150 10.1586/14737140.9.1.143
26. MA Desiderio 2007 Hepatocyte growth factor in invasive growth of carcinomas Cell Mol Life Sci 64 11 1341 1354 10.1007/s00018-007-7050-x
27. A El-Obeid G Hesselager B Westermark 2002 TGF-alpha-driven tumor growth is inhibited by an EGF receptor tyrosine kinase inhibitor Biochem Biophys Res Commun 290 1 349 358 10.1006/bbrc.2001.6210
28. J Bellmunt M Hussain CP Dinney 2003 Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family Crit Rev Oncol Hematol 46 S85 S104 10.1016/S1040-8428(03)00067-2
29. AM Petit J Rak MC Huang 1997 Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors Am J Pathol 151 6 1523 1530 (Pubitemid 27527914)
30. J Okano K Matsumoto T Nagahara 2006 Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells J Gastroenterol 41 2 166 176 10.1007/s00535-005-1736-3
31. M Matsuo H Sakurai K Koizumi 2007 Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells Cancer Lett 251 288 295 10.1016/j.canlet.2006.11.027
32. DL Allen DH TeiteIbaum K Kurachi 2003 Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro Am J Physiol Cell Physiol 284 4 C805 C815 10.1152/ajpcell.00215.2002 (Pubitemid 36336937)
33. H Kargozaran SY Yuan JW Breslin 2007 A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier Clin Exp Metastasis 24 7 495 502 10.1007/s10585-007-9086-6
34. K Lai RM Conwav R Crouch 2008 Expression and distribution of MMPs and TIMPs in human uveal melanoma Exp Eye Res 86 6 936 941 10.1016/j.exer.2008.03. 010
35. JA Werner IO Rathcke R Mandic 2002 The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck Clin Exp Metastasis 19 4 275 282 10.1023/A:1015531319087